<p>A drug for treating schizophrenia which comprises as the active ingredient a compound having an mGluR1 antagonism or a pharmaceutically acceptable salt thereof. More specifically speaking, a drug for treating schizophrenia which comprises as the active ingredient a compound having an mGluR1 antagonism and being represented by the following general formula [1] or a pharmaceutically acceptable salt thereof: [1]</p>
申请公布号
WO2004016287(A1)
申请公布日期
2004.02.26
申请号
WO2003JP10286
申请日期
2003.08.13
申请人
BANYU PHARMACEUTICAL CO.,LTD.;OHTA, HISASHI;TANAKA, TAKESHI;SATO, AKIO;OHKUBO, MITSURU;TSUKAMOTO, NAOHIRO;MITSUYA, MORIHIRO
